Mar 9, 2023
Comments to FDA: Evaluating Drug Names for Similarities
Docket Number:
2003N-0201
Letter to Daniel E. Troy, Esq. regarding whether there should be different trade-name evaluation procedures for different classes of drugs (Rx versus OTC).
Issues: